I Kluijt

Summary

Affiliation: The Netherlands Cancer Institute
Country: The Netherlands

Publications

  1. ncbi Familial gastric cancer: guidelines for diagnosis, treatment and periodic surveillance
    Irma Kluijt
    Family Cancer Clinic, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Fam Cancer 11:363-9. 2012
  2. ncbi CDH1-related hereditary diffuse gastric cancer syndrome: clinical variations and implications for counseling
    Irma Kluijt
    Family Cancer Clinic, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Int J Cancer 131:367-76. 2012
  3. ncbi A novel pathogenic MLH1 missense mutation, c.112A > C, p.Asn38His, in six families with Lynch syndrome
    Els Van Riel
    Department of Medical Genetics, University Medical Centre Utrecht, Lundlaan 6, Utrecht, The Netherlands
    Hered Cancer Clin Pract 8:7. 2010
  4. ncbi Early onset of renal cancer in a family with Birt-Hogg-Dubé syndrome
    I Kluijt
    Family Cancer Clinic, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Clin Genet 75:537-43. 2009
  5. ncbi Atypical familial presentation of FAMMM syndrome with a high incidence of pancreatic cancer: case finding of asymptomatic individuals by EUS surveillance
    Irma Kluijt
    Family Cancer Clinic, The Netherlands Cancer Institute, Academic Medical Centre, Amsterdam, Netherlands
    J Clin Gastroenterol 43:853-7. 2009
  6. ncbi [Familial gastric cancer: diagnosis, treatment and periodic surveillance]
    Irma Kluijt
    Nederlands Kanker Instituut Antoni van Leeuwenhoek Ziekenhuis, Amsterdam, The Netherlands
    Ned Tijdschr Geneeskd 155:A2731. 2011
  7. ncbi TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes
    Marielle W G Ruijs
    Family Cancer Clinic, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Med Genet 47:421-8. 2010

Collaborators

Detail Information

Publications7

  1. ncbi Familial gastric cancer: guidelines for diagnosis, treatment and periodic surveillance
    Irma Kluijt
    Family Cancer Clinic, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Fam Cancer 11:363-9. 2012
    ..National and international collaboration is warranted to improve the quality of research by increasing the size of study cohorts...
  2. ncbi CDH1-related hereditary diffuse gastric cancer syndrome: clinical variations and implications for counseling
    Irma Kluijt
    Family Cancer Clinic, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Int J Cancer 131:367-76. 2012
    ..The relationship between CL/P and CDH1 needs further study to inform future parents from hereditary diffuse gastric cancer (HDGC) families adequately...
  3. ncbi A novel pathogenic MLH1 missense mutation, c.112A > C, p.Asn38His, in six families with Lynch syndrome
    Els Van Riel
    Department of Medical Genetics, University Medical Centre Utrecht, Lundlaan 6, Utrecht, The Netherlands
    Hered Cancer Clin Pract 8:7. 2010
    ..The pathogenicity of this variant was unknown. We aim to elucidate the pathogenicity of this MLH1 variant in order to counsel these families adequately and to enable predictive testing in healthy at-risk relatives...
  4. ncbi Early onset of renal cancer in a family with Birt-Hogg-Dubé syndrome
    I Kluijt
    Family Cancer Clinic, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Clin Genet 75:537-43. 2009
    ..A variety of congenital anomalies and connective tissue abnormalities were observed, possibly associated with the gene mutation...
  5. ncbi Atypical familial presentation of FAMMM syndrome with a high incidence of pancreatic cancer: case finding of asymptomatic individuals by EUS surveillance
    Irma Kluijt
    Family Cancer Clinic, The Netherlands Cancer Institute, Academic Medical Centre, Amsterdam, Netherlands
    J Clin Gastroenterol 43:853-7. 2009
    ..In selected individuals at high risk of developing PC, surveillance of the pancreas might be able to detect premalignant lesions and early invasive cancers, and probably improve survival...
  6. ncbi [Familial gastric cancer: diagnosis, treatment and periodic surveillance]
    Irma Kluijt
    Nederlands Kanker Instituut Antoni van Leeuwenhoek Ziekenhuis, Amsterdam, The Netherlands
    Ned Tijdschr Geneeskd 155:A2731. 2011
    ..In order to optimize the care and increase the knowledge on hereditary gastric cancer it is important to centralize medical care for these patients...
  7. ncbi TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes
    Marielle W G Ruijs
    Family Cancer Clinic, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Med Genet 47:421-8. 2010
    ..In addition to the risk for established LFS tumour types, TP53-positive individuals may also have an elevated risk for pancreatic and colon cancer...